Tumor- and Fibroblast-Derived Cell-Free DNAs Differently Affect the Progression of B16 Melanoma In Vitro and In Vivo

• Published in: International journal of molecular sciences 2024-05, Vol.25 (10), p.5304
• Main Authors: Filatova, Alina A, Alekseeva, Ludmila A, Sen'kova, Aleksandra V, Savin, Innokenty A, Sounbuli, Khetam, Zenkova, Marina A, Mironova, Nadezhda L
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis; Cancer; Cell adhesion & migration; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival - drug effects; cell-free DNA; Cell-Free Nucleic Acids - genetics; Development and progression; Disease Progression; DNA; DNA methylation; DNA, Neoplasm - genetics; DNA, Neoplasm - metabolism; Ethylenediaminetetraacetic acid; fibroblast; Fibroblasts; Fibroblasts - metabolism; Gene expression; Gene Expression Regulation, Neoplastic; Genetic testing; Genomes; Melanoma; Melanoma, Experimental - genetics; Melanoma, Experimental - metabolism; Melanoma, Experimental - pathology; Metastasis; Mice; Mitochondrial DNA; Motility; Oxidative Stress; Scientific equipment and supplies industry; Tumor Microenvironment - genetics; tumor progression; Tumors
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25105304

It is widely postulated that the majority of pathologically elevated extracellular or cell-free DNA (cfDNA) in cancer originates from tumor cells; however, evidence has emerged regarding the significant contributions of other cells from the tumor microenvironment. Here, the effect of cfDNA originating from murine B16 melanoma cells and L929 fibroblasts on B16 cells was investigated. It was found that cfDNAL929 increased the viability and migration properties of B16 cells in vitro and their invasiveness in vivo. In contrast, cfDNAB16 exhibited a negative effect on B16 cells, reducing their viability and migration in vitro, which in vivo led to decreased tumor size and metastasis number. It was shown that cell treatment with both cfDNAs resulted in an increase in the expression of genes encoding DNases and the oncogenes , , and cfDNAL929-treated cells were shown to experience oxidative stress. Gene expression changes in the case of cfDNAB16 treatment are well correlated with the observed decrease in proliferation and migration of B16 cells. The obtained data may indicate the possible involvement of fibroblast DNA in the tumor microenvironment in tumor progression and, potentially, in the formation of new tumor foci due to the transformation of normal cells.